Viviane O Leal1, Juliana F Saldanha2, Milena B Stockler-Pinto3, Ludmila F M F Cardozo3, Felipe R Santos4, Alex S D Albuquerque5, Maurilo Leite5, Denise Mafra3,2. 1. Graduate Program in Cardiovascular Sciences, Federal Fluminense University (UFF), Rua Marques do Paraná, 303. Prédio Anexo, 6º andar., Niterói, RJ, 24033-900, Brazil. vivianeoleal@yahoo.com.br. 2. Graduate Program in Medical Sciences, Federal Fluminense University (UFF), Niterói, RJ, Brazil. 3. Graduate Program in Cardiovascular Sciences, Federal Fluminense University (UFF), Rua Marques do Paraná, 303. Prédio Anexo, 6º andar., Niterói, RJ, 24033-900, Brazil. 4. Lagoa Hospital, Rio de Janeiro, RJ, Brazil. 5. Division of Nephrology, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.
Abstract
PURPOSE: To evaluate nuclear factor erythroid 2-related factor 2 (Nrf2) and nuclear factor-kappaB (NF-κB) mRNA expression in nondialysis chronic kidney disease (CKD) patients, comparing with data from hemodialysis (HD) patients and healthy individuals. METHODS: Twenty nondialysis CKD patients (62.0 ± 8.1 years old, 11 men, estimated glomerular filtration rate of 36.8 ± 13.6 mL/min/1.73 m(2)), twenty HD patients (55.0 ± 15.2 years old, 13 men, and dialysis vintage of 76.5 ± 46.3 months) and eleven healthy individuals (50.9 ± 8.0 years old, 6 men) were enrolled in the study. The peripheral blood mononuclear cells were isolated and processed for the evaluation of expression of NF-κB and Nrf2 by quantitative real-time polymerase chain reaction. RESULTS: Nrf2 mRNA expression was significantly higher in nondialysis (1.12 ± 0.57) when compared to HD patients (0.58 ± 0.35, p = 0,006) but similar to healthy individuals (1.13 ± 0.64). Inversely, NF-κB mRNA expression was lower in nondialysis (1.21 ± 0.71) when compared to HD patients (2.08 ± 0.7, p < 0.0001) and similar to healthy individuals (1.04 ± 0.22). Nrf2 mRNA was positively correlated with NF-κB mRNA expression in nondialysis CKD patients (r = 0.52, p = 0.02) and healthy individuals (r = 0.77, p < 0.006). By contrast, Nrf2 mRNA was inversely correlated with NF-κB mRNA expression (r = -0.65, p = 0.003) in HD patients. CONCLUSION: Nondialysis CKD patients may conserve regular homeostatic balance between Nrf2 and NF-κB expressions, being comparable to healthy individuals. However, HD patients seem to have Nrf2 downregulation and NF-κB upregulation. Thus, the association among Nrf2 and NF-κB expressions and nutritional status, kidney disease progression or immune deregulation deserve further investigation.
PURPOSE: To evaluate nuclear factor erythroid 2-related factor 2 (Nrf2) and nuclear factor-kappaB (NF-κB) mRNA expression in nondialysis chronic kidney disease (CKD) patients, comparing with data from hemodialysis (HD) patients and healthy individuals. METHODS: Twenty nondialysis CKDpatients (62.0 ± 8.1 years old, 11 men, estimated glomerular filtration rate of 36.8 ± 13.6 mL/min/1.73 m(2)), twenty HDpatients (55.0 ± 15.2 years old, 13 men, and dialysis vintage of 76.5 ± 46.3 months) and eleven healthy individuals (50.9 ± 8.0 years old, 6 men) were enrolled in the study. The peripheral blood mononuclear cells were isolated and processed for the evaluation of expression of NF-κB and Nrf2 by quantitative real-time polymerase chain reaction. RESULTS:Nrf2 mRNA expression was significantly higher in nondialysis (1.12 ± 0.57) when compared to HDpatients (0.58 ± 0.35, p = 0,006) but similar to healthy individuals (1.13 ± 0.64). Inversely, NF-κB mRNA expression was lower in nondialysis (1.21 ± 0.71) when compared to HDpatients (2.08 ± 0.7, p < 0.0001) and similar to healthy individuals (1.04 ± 0.22). Nrf2 mRNA was positively correlated with NF-κB mRNA expression in nondialysis CKDpatients (r = 0.52, p = 0.02) and healthy individuals (r = 0.77, p < 0.006). By contrast, Nrf2 mRNA was inversely correlated with NF-κB mRNA expression (r = -0.65, p = 0.003) in HDpatients. CONCLUSION: Nondialysis CKDpatients may conserve regular homeostatic balance between Nrf2 and NF-κB expressions, being comparable to healthy individuals. However, HDpatients seem to have Nrf2 downregulation and NF-κB upregulation. Thus, the association among Nrf2 and NF-κB expressions and nutritional status, kidney disease progression or immune deregulation deserve further investigation.
Authors: Liliana M Pedruzzi; Ludmila F M F Cardozo; Julio B Daleprane; Milena B Stockler-Pinto; Elisa B Monteiro; Maurilo Leite; Nosratola D Vaziri; Denise Mafra Journal: J Nephrol Date: 2015-01-14 Impact factor: 3.902
Authors: Hongting Zheng; Samantha A Whitman; Wei Wu; Georg T Wondrak; Pak K Wong; Deyu Fang; Donna D Zhang Journal: Diabetes Date: 2011-11 Impact factor: 9.461
Authors: Gianluigi Zaza; Simona Granata; Valentina Masola; Carlo Rugiu; Francesco Fantin; Loreto Gesualdo; Francesco Paolo Schena; Antonio Lupo Journal: PLoS One Date: 2013-10-28 Impact factor: 3.240
Authors: Milena B Stockler-Pinto; Christophe O Soulage; Natália A Borges; Ludmila F M F Cardozo; Carla J Dolenga; Lia S Nakao; Roberto Pecoits-Filho; Denis Fouque; Denise Mafra Journal: Int Urol Nephrol Date: 2017-11-18 Impact factor: 2.370
Authors: Peter Stenvinkel; Glenn M Chertow; Prasad Devarajan; Adeera Levin; Sharon P Andreoli; Sripal Bangalore; Bradley A Warady Journal: Kidney Int Rep Date: 2021-05-04